TickerFacts.

Intellia Therapeutics, Inc. (NTLA): Net Income

Annual figures by period end, from SEC filings.

-$412.69M
Year ended 2025-12-31
-$399.98M
Trailing 12 months to 2026-06-30
2015-12-31: -$12.40M2016-12-31: -$31.63M2017-12-31: -$67.54M2018-12-31: -$85.34M2019-12-31: -$474.19M2020-12-31: -$134.23M2021-12-31: -$267.89M2022-12-31: -$474.19M2023-12-31: -$481.19M2024-12-31: -$519.02M2025-12-31: -$412.69M-$412.69M
2015-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$412.69Mn/m2026-02-26, From 2025-01-01
2024-12-31-$519.02Mn/m2026-02-26, From 2024-01-01
2023-12-31-$481.19Mn/m2026-02-26, From 2023-01-01
2022-12-31-$474.19Mn/m2025-02-27, From 2022-01-01
2021-12-31-$267.89Mn/m2024-02-22, From 2021-01-01
2020-12-31-$134.23Mn/m2023-02-23, From 2020-01-01
2019-12-31-$474.19Mn/m2023-02-23, From 2019-01-01
2018-12-31-$85.34Mn/m2021-02-26, From 2018-01-01
2017-12-31-$67.54Mn/m2020-02-27, From 2017-01-01
2016-12-31-$31.63Mn/m2019-02-27, From 2016-01-01
2015-12-31-$12.40Mn/a2018-03-14, From 2015-01-01

Net Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$412.69Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$17.26Mn/m
Immucell Corp (ICCC)2025-12-31-$1.04Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$12.78Mn/m
Anbio Biotechnology (NNNN)2025-12-31$6.40M+169.9%
Myriad Genetics Inc (MYGN)2025-12-31-$365.90Mn/m
Neogen Corp (NEOG)2026-05-31-$7.90Mn/m
Biomerica Inc (BMRA)2026-05-31-$3.77Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$50.22Mn/m

Compare NTLA, TKNO, ICCC, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗